Guardant Health receives FDA approval for companion diagnostic test

June 11, 2026 8:05 AM

Guardant Health Inc. (NASDAQ: GH) announced the U.S. Food and Drug Administration approved its Guardant360 CDx as a companion diagnostic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found